Lazard Asset Management LLC Emergent Bio Solutions Inc. Transaction History

Lazard Asset Management LLC

  • $58.2 Billion
  • Q1 2025

A detailed history of Lazard Asset Management LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 6,344 shares of EBS stock, worth $38,381. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,344
Previous 55,303 88.53%
Holding current value
$38,381
Previous $528,000 94.32%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$4.66 - $11.66 $228,148 - $570,861
-48,959 Reduced 88.53%
6,344 $30,000
Q4 2024

Feb 14, 2025
BUY
$7.72 - $11.97 $360,338 - $558,711
46,676 Added 541.05%
55,303 $528,000
Q3 2024

Nov 14, 2024
SELL
$5.72 - $14.77 $530,993 - $1.37 Million
-92,831 Reduced 91.5%
8,627 $72,000
Q2 2024

Aug 14, 2024
BUY
$1.86 - $6.98 $188,711 - $708,176
101,458 New
101,458 $691,000
Q3 2023

Nov 14, 2023
BUY
$3.17 - $7.91 $84,898 - $211,845
26,782 New
26,782 $91,000
Q4 2022

Feb 14, 2023
BUY
$11.0 - $21.45 $52,613 - $102,595
4,783 New
4,783 $56,000
Q1 2022

May 13, 2022
BUY
$36.48 - $52.22 $65,007 - $93,056
1,782 New
1,782 $73,000
Q4 2021

Feb 09, 2022
SELL
$33.11 - $55.01 $41,751 - $69,367
-1,261 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$50.07 - $66.05 $11,566 - $15,257
-231 Reduced 15.48%
1,261 $63,000
Q2 2021

Aug 12, 2021
SELL
$56.61 - $80.46 $20.9 Million - $29.7 Million
-369,646 Reduced 99.6%
1,492 $93,000
Q1 2021

May 14, 2021
BUY
$86.23 - $125.19 $1.88 Million - $2.73 Million
21,814 Added 6.24%
371,138 $34.5 Million
Q4 2020

Feb 11, 2021
BUY
$79.17 - $111.47 $1.2 Million - $1.7 Million
15,206 Added 4.55%
349,324 $31.3 Million
Q3 2020

Nov 13, 2020
BUY
$81.91 - $134.94 $432,730 - $712,888
5,283 Added 1.61%
334,118 $34.5 Million
Q2 2020

Aug 13, 2020
SELL
$54.33 - $89.52 $2.5 Million - $4.11 Million
-45,935 Reduced 12.26%
328,835 $26 Million
Q1 2020

May 14, 2020
SELL
$49.34 - $68.76 $8.11 Million - $11.3 Million
-164,285 Reduced 30.48%
374,770 $21.7 Million
Q4 2019

Feb 13, 2020
SELL
$51.21 - $59.06 $2.93 Million - $3.37 Million
-57,140 Reduced 9.58%
539,055 $29.1 Million
Q3 2019

Nov 14, 2019
SELL
$40.6 - $57.2 $5.01 Million - $7.06 Million
-123,435 Reduced 17.15%
596,195 $31.2 Million
Q2 2019

Aug 14, 2019
BUY
$39.92 - $53.86 $28.7 Million - $38.8 Million
719,630 New
719,630 $34.8 Million

Others Institutions Holding EBS

# of Institutions
177
Shares Held
38.3M
Call Options Held
94.1K
Put Options Held
153K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $302M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email